Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.29 | 0.08 |